Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Drug Therapy01:28

Drug Therapy

346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
346
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

334
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
334
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

49
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
49
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

242
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
242
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

66
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
66

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Addressing Sub-Saharan Africa's Hypertension Care Crisis Through a Data-Driven Approach.

Journal of the American College of Cardiology·2025
Same author

Adapting Cardiovascular Disease Data to Inform Policy Goals: Global to Local.

Journal of the American College of Cardiology·2025
Same author

WHF Roadmap on Single Pill Combination Therapies.

Global heart·2025
Same author

Evaluating Blood Pressure Response Patterns to Exercise Stress Testing.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of Hypertension.

JACC. Advances·2025
Same author

Consumer perceptions and preferences of pharmacist-led professional services and attributes in Australia: a qualitative focus group study.

BMJ open·2025
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Mar 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K

Poner en práctica las polipíldoras: desafíos y lecciones aprendidas

Ruth Webster1, Jose M Castellano2, Oyere K Onuma3

  • 1George Institute for Global Health, University of Sydney, Sydney, Australia.

Lancet (London, England)
|March 15, 2017
PubMed
Resumen
Este resumen es generado por máquina.

Las polipíldoras cardiovasculares mejoran la adherencia del paciente y los factores de riesgo de enfermedad cardíaca. La aplicación generalizada se enfrenta a desafíos como la falta de reembolso y la participación de los médicos, lo que dificulta los beneficios para la salud pública.

Más Videos Relacionados

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.5K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

Videos de Experimentos Relacionados

Last Updated: Mar 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.5K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

Área de la Ciencia:

  • Medicina cardiovascular
  • Política de salud pública
  • Farmacología

Sus antecedentes:

  • Las aprobaciones regulatorias para polipíldoras cardiovasculares se están expandiendo a nivel mundial.
  • Las polipíldoras demuestran una mejor adherencia y control de los factores de riesgo en pacientes con enfermedades cardiovasculares o de alto riesgo.
  • Los datos de ensayos clínicos existentes apoyan la eficacia y seguridad de las polipíldoras.

Objetivo del estudio:

  • Revisar el impacto clínico y los desafíos de implementación de las polipíldoras cardiovasculares.
  • Identificar las barreras para la adopción clínica generalizada y la realización de beneficios para la salud pública.

Principales métodos:

  • Análisis de la literatura de ensayos clínicos sobre las estrategias de la polipíldora.
  • Revisión de las experiencias de implementación en el mundo real tras el despliegue comercial.
  • Evaluación de los factores que influyen en la captación de médicos y el reembolso del gobierno.

Principales resultados:

  • Las polipíldoras mejoran significativamente la adherencia y el control de los factores de riesgo cardiovascular en comparación con el cuidado habitual.
  • La rentabilidad y la seguridad del uso de polipíldoras están respaldadas por pruebas clínicas.
  • Las principales barreras de implementación incluyen la falta de reembolso del gobierno y la baja adopción de médicos.

Conclusiones:

  • Las polipíldoras cardiovasculares ofrecen beneficios clínicos sustanciales, pero enfrentan obstáculos significativos en la implementación en el mundo real.
  • Superar las barreras requiere esfuerzos coordinados en educación, promoción y cambios de políticas.
  • Las agencias globales, los organismos nacionales y los gobiernos deben respaldar y apoyar la integración de la polipíldora para lograr el máximo impacto en la salud pública.